CC BY 4.0 · AIMS Genet 2019; 06(02): 014-016
DOI: 10.3934/genet.2019.2.14
Editorial

Histone glycation: Linking metabolic perturbation with epigenetic misregulation in cancer

Xiayao Diao
1   Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Yingfeng Road, Haizhu District, Guangzhou 510220, P. R. China
› Author Affiliations

Abbreviations

ROS: Reactive oxygen species
MGO: Methylglyoxal
AGE: Advanced glycation end-product
NCP: Nucleosome core particle
PTM: Post-translational modification



Publication History

Received: 31 May 2019

Accepted: 31 May 2019

Article published online:
15 March 2021

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Wang Y, Xia Y, Lu Z. Metabolic features of cancer cells. Cancer Commun 2018; 38: 65
  • 2 Wang Y, Lei Q. Metabolic recoding of epigenetics in cancer. Cancer Commun 2018; 38: 25
  • 3 Oya T, Hattori N, Mizuno Y. et al. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999; 274: 18492-18502
  • 4 Perche F, Biswas S, Patel NR. et al. Hypoxia-Responsive Copolymer for siRNA Delivery. Methods Mol Biol 2016; 1372: 139-162
  • 5 Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293: 1074-1080
  • 6 Bartholomew B. Regulating the chromatin landscape: Structural and mechanistic perspectives. Annu Rev Biochem 2014; 83: 671-696
  • 7 Guedes S, Vitorino R, Domingues MR. et al. Glycation and oxidation of histones H2B and H1: In vitro study and characterization by mass spectrometry. Anal Bioanal Chem 2011; 399: 3529-3539
  • 8 Zheng Q, Omans ND, Leicher R. et al. Reversible histone glycation is associated with disease-related changes in chromatin architecture. Nature Commun 2019; 10: 1289
  • 9 Ariga H. DJ-1/PARK7 Protein: Parkinson's Disease, Cancer and Oxidative Stress-Induced Diseases. Adv Exp Med Biol 2017; 1037: 224
  • 10 Cao J, Lou S, Ying M. et al. DJ-1 as a human oncogene and potential therapeutic target. Biochem Pharmacol 2015; 93: 241-250